Australia markets closed

Zynex, Inc. (ZYXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.52+0.23 (+2.24%)
At close: 04:00PM EDT
10.52 0.00 (0.00%)
After hours: 04:00PM EDT

Zynex, Inc.

9655 Maroon Circle
Englewood, CO 80112
United States
303 703 4906
https://www.zynex.com

Sector(s)Healthcare
IndustryMedical Distribution
Full-time employees1,100

Key executives

NameTitlePayExercisedYear born
Mr. Thomas SandgaardFounder, President, CEO & Chairman992.83k1.66M1959
Mr. Daniel J. MoorheadChief Financial Officer472.61kN/A1972
Ms. Anna LucsokChief Operating Officer400.84kN/A1987
Mr. Steve FoxVice President Of SalesN/AN/AN/A
Mr. Donald GreggPresident of Zynex Monitoring SolutionsN/AN/AN/A
Mr. Neil FrieryPresident & COO of Zynex Monitoring Solutions, Inc.N/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Corporate governance

Zynex, Inc.’s ISS governance QualityScore as of 1 May 2024 is 8. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.